Bridgefront Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$267K Sell
2024
Q4
$680K Buy
2024
Q3
Sell
2024
Q2
$243K Buy
2024
Q1
Sell
2023
Q4
$258K Buy
2023
Q3
Sell
2023
Q2
$302K Buy